Safety Profile

Epithalon Side Effects & Safety

Epithalon has a favorable safety profile in Russian cohort studies. Western safety data is limited.

Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.

Side effects by severity

Common1 effect

Injection site reactions

Mild redness or discomfort.

Uncommon2 effects

Drowsiness

Related to pineal gland modulation.

Sleep pattern changes

Some users report vivid dreams or altered sleep.

Rare1 effect

Allergic reactions

Rare hypersensitivity.

Contraindications

Pregnancy and lactation
Known hypersensitivity
Active malignancy (theoretical concern with telomerase activation)

Drug interactions

Limited published data
Theoretical interaction with melatonin or sleep-regulating agents

Special populations

Not FDA approved. Russian elderly cohort data suggests safety in older populations.

Safety summary

Epithalon has been well-tolerated in Russian elderly populations over decades. Theoretical concerns about telomerase activation in latent malignancy remain unresolved.

Frequently asked

Can Epithalon promote cancer growth?

No direct evidence exists. However, telomerase activation is a theoretical concern in patients with active or latent malignancy, since many cancers upregulate telomerase to escape senescence.